cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Haemonetics Corp
1 own
1 watching
Current Price
$90.05
$-0.04
(-0.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,623.17M
52-Week High
52-Week High
95.26
52-Week Low
52-Week Low
71.63
Average Volume
Average Volume
0.22M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
58.9186
iconMarket Capitalization4,623.17M
icon52-Week High95.26
icon52-Week Low71.63
iconAverage Volume0.22M
iconDividend Yield--
iconP/E Ratio58.9186
What does the Haemonetics Corp do?
Haemonetics Corporation, a healthcare company, provides products for processing, handling, and analysis of blood. The company operates through five segments: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection, filtration, and processing products. The company also offers hospital products comprising TEG thrombelastograph hemostasis analyzer system, a blood diagnostic instrument that measure a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver system, a surgical blood salvage system for cardiovascular surgeries; and OrthoPAT surgical blood salvage systems for orthopedic procedures. In addition, it offers SafeTrace Tx, a software solution that manages blood product inventory and transfusion, as well as performs patient cross-matching; and BloodTrack suite of solutions for managing, tracking, and controlling blood products from the hospital blood center through to transfusion to the patient. The company markets and sells its products to bio-pharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.
Read More
How much money does Haemonetics Corp make?
News & Events about Haemonetics Corp.
Ticker Report
7 months ago
Haemonetics Co. (NYSE:HAE Get Rating) has been given an average rating of Moderate Buy by the eight brokerages that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company...
Zolmax
7 months ago
Haemonetics (NYSE:HAE Get Rating) had its price objective raised by Barrington Research from $94.00 to $103.00 in a report published on Wednesday morning, The Fly reports. Barrington Research currently has an outperform rating on the medical instruments suppliers stock. Barrington Research also ...
Benzinga
7 months ago
read more...
Benzinga
8 months ago
Latest Ratings for HAE DateFirmActionFromTo Feb 2022Raymond JamesMaintainsOutperform Jan 2022NeedhamDowngradesBuyHold Jan 2022Morgan StanleyMaintainsEqual-Weight View More Analyst Ratings for HAE View the Latest Analyst Ratings read more...
Zolmax
9 months ago
Haemonetics (NYSE:HAE Get Rating) had its price objective raised by Citigroup from $88.00 to $92.00 in a report released on Monday morning, The Fly reports. Citigroup currently has a neutral rating on the medical instruments suppliers stock. HAE has been the topic of a number of other reports. ...
Frequently Asked Questions
Frequently Asked Questions
What is Haemonetics Corp share price today?
plus_minus_icon
Can Indians buy Haemonetics Corp shares?
plus_minus_icon
How can I buy Haemonetics Corp shares from India?
plus_minus_icon
Can Fractional shares of Haemonetics Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Haemonetics Corp stocks?
plus_minus_icon
What is today’s traded volume of Haemonetics Corp?
plus_minus_icon
What is today’s market capitalisation of Haemonetics Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Haemonetics Corp?
plus_minus_icon
What percentage is Haemonetics Corp down from its 52-Week High?
plus_minus_icon
What percentage is Haemonetics Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$90.05
$-0.04
(-0.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Penumbra Inc
Penumbra Inc
$247.70
$-2.66 (-1.06 %)
Lantheus Holdings
Lantheus Holdings
$61.82
$1.55 (2.57 %)
Globus Medical, Inc.
Globus Medical, Inc.
$50.77
$-0.32 (-0.63 %)
Glaukos Corp
Glaukos Corp
$75.28
$0.03 (0.04 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Penumbra Inc
Penumbra Inc
$247.70
$-2.66 (-1.06 %)
Lantheus Holdings
Lantheus Holdings
$61.82
$1.55 (2.57 %)
Globus Medical, Inc.
Globus Medical, Inc.
$50.77
$-0.32 (-0.63 %)
Glaukos Corp
Glaukos Corp
$75.28
$0.03 (0.04 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00